BHV3000 (Rimegepant)

rimegepant · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BHV3000 (Rimegepant), covering 2023-12-14 to 2023-12-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine [Phase 3]